Clinigen Group PLC | Balance Sheet

Fiscal year is July-June. All values GBP Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
11,326.00
21,787.00
27,800.00
27,800.00
28,800.00
36,300
Total Accounts Receivable
21,419.00
25,176.00
59,200.00
68,800.00
65,900.00
95,900
Inventories
3,151.00
2,466.00
11,100.00
15,600.00
16,700.00
21,300
Other Current Assets
1,234.00
2,003.00
11,900.00
-
-
-
Total Current Assets
37,130.00
51,432.00
110,000.00
112,200.00
111,400.00
153,500
Net Property, Plant & Equipment
748.00
968.00
1,600.00
2,700.00
3,300.00
6,800
Total Investments and Advances
-
-
-
7,400.00
8,700.00
6,600
Intangible Assets
38,893.00
50,508.00
302,500.00
334,100.00
332,500.00
497,600
Total Assets
78,754.00
104,864.00
419,100.00
459,900.00
459,500.00
667,100
ST Debt & Current Portion LT Debt
-
16,500.00
69,500.00
70,000.00
45,500.00
Accounts Payable
6,249.00
10,275.00
48,100.00
68,600.00
54,800.00
Income Tax Payable
-
2,555.00
2,900.00
1,400.00
7,500.00
Other Current Liabilities
21,555.00
9,227.00
40,500.00
24,300.00
63,900.00
Total Current Liabilities
27,804.00
38,557.00
161,000.00
164,300.00
171,700.00
Long-Term Debt
-
-
34,500.00
25,900.00
17,300.00
Deferred Taxes
1,983.00
1,956.00
14,000.00
18,700.00
16,500.00
Other Liabilities
-
-
-
11,000.00
1,300.00
Total Liabilities
27,804.00
38,557.00
214,500.00
223,400.00
210,400.00
Common Equity (Total)
50,950.00
66,307.00
204,600.00
236,500.00
249,100.00
Total Shareholders' Equity
50,950.00
66,307.00
204,600.00
236,500.00
249,100.00
Total Equity
50,950.00
66,307.00
204,600.00
236,500.00
249,100.00
Liabilities & Shareholders' Equity
78,754.00
104,864.00
419,100.00
459,900.00
459,500.00

About Clinigen Group

View Profile
Address
Pitcairn House
Burton-on-Trent Staffordshire DE14 2WW
United Kingdom
Employees -
Website http://clinigen.co.uk
Updated 07/08/2019
Clinigen Group Plc engages in the provision of pharmaceutical products and services. It operates through the following segments: Clinigen Clinical Trial Services (CTS), Idis Managed Access (MA), Idis Global Access (GA), Clinigen Specialty Pharmaceuticals (SP), and Link Health Care. The Clinigen CTS segment sources commercial medical products for use in clinical studies, including comparator drugs, adjuvant drugs and rescue therapies.